Free sphingoid bases in tissues from patients with type C Niemann-Pick disease and other lysosomal storage disorders.

[1]  K. Sandhoff,et al.  Biosynthesis of sphingolipids: dihydroceramide and not sphinganine is desaturated by cultured cells. , 1992, Biochemical and biophysical research communications.

[2]  Takurou Kobayashi,et al.  Accumulation of Lysosphingolipids in Tissues from Patients with GM1 and GM2 Gangliosidoses , 1992, Journal of neurochemistry.

[3]  J. Mendelsohn,et al.  Ceramide stimulates epidermal growth factor receptor phosphorylation in A431 human epidermoid carcinoma cells. Evidence that ceramide may mediate sphingosine action. , 1991, The Journal of biological chemistry.

[4]  A. Mendez,et al.  Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol. , 1991, The Journal of biological chemistry.

[5]  R. Rousson,et al.  Type C Niemann-Pick disease: spectrum of phenotypic variation in disruption of intracellular LDL-derived cholesterol processing. , 1991, Biochimica et biophysica acta.

[6]  Y. Eto,et al.  Lysosulfatide (Sulfogalactosylsphingosine) Accumulation in Tissues from Patients with Metachromatic Leukodystrophy , 1990, Journal of neurochemistry.

[7]  D. D. Jones,et al.  An update of the enzymology and regulation of sphingomyelin metabolism. , 1990, Biochimica et biophysica acta.

[8]  R. Rousson,et al.  Abnormal cholesterol metabolism in imipramine-treated fibroblast cultures. Similarities with Niemann-Pick type C disease. , 1990, Biochimica et biophysica acta.

[9]  L. Liscum,et al.  The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. , 1989, The Journal of biological chemistry.

[10]  G. Gibori,et al.  Protein kinase C catalyzed phosphorylation of sterol carrier protein 2. , 1989, Endocrinology.

[11]  A. Merrill,et al.  Free sphingosine formation from endogenous substrates by a liver plasma membrane system with a divalent cation dependence and a neutral pH optimum. , 1989, The Journal of biological chemistry.

[12]  Takurou Kobayashi,et al.  Infantile and fetal globoid cell leukodystrophy: Analysis of galactosylceramide and galactosylsphingosine , 1988, Annals of neurology.

[13]  A. Merrill,et al.  Modulation of the free sphingosine levels in human neutrophils by phorbol esters and other factors. , 1988, The Journal of biological chemistry.

[14]  A. Merrill,et al.  Quantitation of free sphingosine in liver by high-performance liquid chromatography. , 1988, Analytical biochemistry.

[15]  R. Brady,et al.  Niemann‐Pick disease group C: clinical variability and diagnosis based on defective cholesterol esterification: A collaborative study on 70 patients , 1988, Clinical genetics.

[16]  J. Månsson,et al.  Composition of Gangliosides and Neutral Glycosphingolipids of Brain in Classical Tay‐Sachs and Sandhoff Disease: More Lyso‐GM2 in Sandhoff Disease? , 1987, Journal of neurochemistry.

[17]  P. Cullis,et al.  Lipid asymmetry induced by transmembrane pH gradients in large unilamellar vesicles. , 1987, The Journal of biological chemistry.

[18]  R. Massarelli,et al.  Enzymes of Lipid Metabolism II , 1986, NATO ASI Series.

[19]  Y. Hannun,et al.  Inhibition of phorbol ester-dependent differentiation of human promyelocytic leukemic (HL-60) cells by sphinganine and other long-chain bases. , 1986, The Journal of biological chemistry.

[20]  Y. Hannun,et al.  Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets. , 1986, The Journal of biological chemistry.

[21]  A. Merrill,et al.  Inhibition of the oxidative burst in human neutrophils by sphingoid long-chain bases. Role of protein kinase C in activation of the burst. , 1986, The Journal of biological chemistry.

[22]  R. Brady,et al.  A genetic storage disorder in BALB/C mice with a metabolic block in esterification of exogenous cholesterol. , 1984, The Journal of biological chemistry.

[23]  M. Vanier.  Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. , 1983, Biochimica et biophysica acta.

[24]  L. Svennerholm,et al.  Accumulation of Glucosylceramide and Glucosylsphingosine (Psychosine) in Cerebrum and Cerebellum in Infantile and Juvenile Gaucher Disease , 1982, Journal of neurochemistry.

[25]  J. Kanfer,et al.  Isolation and characterization of glucosylsphingosine from Gaucher's spleen. , 1974, Journal of lipid research.

[26]  E. Hartree,et al.  Determination of protein: a modification of the Lowry method that gives a linear photometric response. , 1972, Analytical biochemistry.

[27]  Yoshiyuki Suzuki,et al.  GM2‐gangliosidosis with total hexosaminidase deficiency , 1971, Neurology.

[28]  K. Suzuki,et al.  Infantile Niemann-Pick disease. A chemical study with isolation and characterization of membranous cytoplasmic bodies and myelin. , 1969, American journal of diseases of children.

[29]  Kinuko Suzuki,et al.  ISOLATION AND CHEMICAL CHARACTERIZATION OF METACHROMATIC GRANULES FROM A BRAIN WITH METACHROMATIC LEUKODYSTROPHY , 1967, Journal of neuropathology and experimental neurology.

[30]  R. Brady,et al.  Type C Niemann-Pick disease: use of hydrophobic amines to study defective cholesterol transport. , 1991, Developmental neuroscience.

[31]  Charles R.scriver.  The Metabolic basis of inherited disease , 1989 .

[32]  R. Salvayre,et al.  Lipid storage disorders : biological and medical aspects , 1988 .

[33]  M. Brown,et al.  Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. , 1983, Methods in enzymology.

[34]  J. Månsson,et al.  Krabbe disease: a galactosylsphingosine (psychosine) lipidosis. , 1980, Journal of lipid research.